Speciality: Urology
Description:
Welcome to today’s episode, where we’ll explore the early warning signs of kidney stones. Kidney stones can develop silently, but there are some key symptoms you shouldn’t ignore. The most common early sign is pain in your lower back or side, which may come and go. You might also notice changes in your urine, such as a pink or brown colour, cloudiness, or a strong odour. Frequent urge to urinate, pain during urination, or difficulty passing urine can also indicate a problem. Nausea and vomiting sometimes occur as well. If you experience any of these symptoms, it’s important to consult a healthcare professional promptly. Early detection can help prevent complications and lead to more effective treatment.
See More Webinars @ Hidoc Webinars
1.
Microplastics can cause malignant changes in lung cells
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer
1.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
2.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
3.
Innovative Approaches in Oncology for Modern Medicine
4.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
5.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Screening in Cancer Prevention
2.
From Guidelines to Practice: Hematology
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation